Objective-Cell-mediated immune responses in peripheral tissues begin with T cell infiltration through endothelial cell (EC) microvessels and accumulation in the perivascular space occupied by pericytes (PC). Here, we investigate how human T cells interact with PC. Methods and Results-We compared human placental PC with autologous umbilical vein EC. Cultured PC express lower levels of major histocompatibility complex (MHC) and positive costimulatory molecules but higher levels of negative costimulatory molecules than do EC. Unlike EC, interferon-␥-treated MHC class II-positive PC (PC ϩ ) cannot stimulate resting allogeneic CD4 T cell proliferation or cytokine production. Instead, coculture of resting CD4 T cells with PC ϩ induces CD25 expression and renders T cells unresponsive to restimulation by EC ϩ from the same donor. PC cultured across a semi-permeable membrane decrease alloreactive CD4 T cell proliferation to EC ϩ , an effect enhanced by pretreatment of PC with interferon-␥ and partially reversed by interleukin-10 and transforming growth factor-␤ neutralization, but do not induce anergy.
T he effector phase of T cell-mediated immune responses begins with recruitment of T cells through postcapillary venules. 1, 2 Such microvessels are composed of an endothelial cell (EC) lining supported by a network of perivascular cells, called pericytes (PC). 3, 4 Venular EC inducibly display luminal adhesion molecules and chemokines that mediate recruitment of circulating effector memory T cells (reviewed in Choi et al 5 ). In addition, human EC basally express both class I and class II major histocompatibility complex (MHC) molecules in situ, 6, 7 mostly likely in response to circulating interferon (IFN)-␥. 8 T cell recognition of MHC molecules on EC in vitro triggers chemokine-independent transendothelial migration of effector memory T cells. 9 -11 In vivo, transmigrated T cells typically remain in a perivascular location, in close proximity to PC, for extended periods of time.
CD4 T cell activation requires 2 signals: antigen, composed of self-MHC-foreign peptide complexes or, in allogeneic settings, of nonself MHC-peptide complexes; and antigen-independent costimulators that positively or negatively influence responses. Recognition of antigen in the absence of costimulation can cause anergy such that CD4 T cells are unable to respond to subsequent antigenic stimulation. 12 Human EC can act as "semiprofessional" antigen-presenting cells, stimulating approximately 20% to 40% as many resting T cells to proliferate and elaborate cytokines as do monocytes or B lymphoblastoid cells. [13] [14] [15] This quantitative difference in accessory cell function is largely due to the fact that human EC lack costimulators that engage CD28 on T cells, namely CD80 and CD86, and CD28 signals are essential for the activation of naïve T cells. Consequently, EC are able to activate only alloreactive memory T cells, whereas classical antigen-presenting cells, which do express CD80 and CD86, can activate both alloreactive naïve and memory T cells. 16 EC do express other costimulators that are specific for the activation of memory T cells, namely CD58 (lymphocyte function-associated antigen [LFA]-3), CD40, CD275 (inducible T cell costimulator [ICOS] ligand), CD137L (41BB ligand), and CD252 (Ox40 ligand). 14 -16 Vascular smooth muscle cells, which lack CD275 and CD252, as well as CD80 and CD86, are unable to activate either naïve or memory T cells. 17 In contrast to EC, many stromal cell types lacking antigenpresenting cell capabilities inhibit T cell responses. For example, undifferentiated bone marrow-derived mesenchymal stem cells (MSC) and tissue-derived mesenchymal progenitor cells inhibit lymphocyte responses by nutrient consumption or production of inhibitory factors. 18, 19 Specifically, interleukin (IL)-10, transforming growth factor (TGF)-␤, and prostaglandin E2 (PGE2) contribute to human MSC-mediated T cell suppression. 20, 21 Human aortic smooth muscle cells inhibit T cell responses 22 by depleting L-tryptophan through the activity of indoleamine 2,3-dioxygenase (IDO). 23 Immune-inhibitory abilities may characterize all mesenchymal cell types. 24 However, immune functions of differentiated PC, anatomically positioned to exert modulatory effects on perivascular T cells, have not been previously examined.
The principal reason for the lack of information about PC immunology is that human PC have not been readily available for study. Recently, we developed a method for the isolation of human PC from placental microvessels, allowing comparison of the immunologic characteristics of PC to those of EC isolated from the same donor. 25 We report here that PC are not immunogenic and actively regulate alloreactive CD4 T cell responses.
Methods

Cells and Reagents
Human placental PC, umbilical vein EC, and peripheral blood CD4 T cells were obtained following institutional review board-approved protocols. Placental PC were cultured by explant outgrowth from microvessel fragments recovered after enzymatic digestion of minced placental tissue, umbilical vein EC were harvested with collagenase treatment, and CD4 T cells were purified from leukapheresis collections by positive immunoselection. Detailed procedures are presented in the Supplemental Methods, available online at http://atvb.ahajournals.org. Placental PC express characteristic markers NG2, CD90 (Thy-1), CD146, and ␣-smooth muscle actin and lack contamination by cells expressing CD31 or CD34 (EC markers) or CD14 or CD45 (leukocytes). Human brain PC were purchased from ScienCell and confirmed to express NG2, CD146, and ␣-smooth muscle actin. PC and EC were used between subcultures 2 and 6. Conditions for cultures and cocultures have been reported previously 25 and are described in the Supplemental Methods, as are sources and concentrations of all cytokines, reagents, and antibodies.
Statistical Analysis
Statistical analyses were performed using the appropriate parametric or nonparametric tests as indicated.
Results
PC Express an Immunophenotype Distinct From That of EC
We compared placental PC and autologous human umbilical vein EC for expression of immunologically significant surface molecules under basal and cytokine-stimulated conditions. Like EC, PC expressed MHC class I molecules but not class II molecules under basal culture conditions; both class I and class II MHC molecule expression were induced following treatment with IFN-␥ (Table) . However, MHC molecule expression was lower on PC than EC. Neither PC nor EC expressed the costimulatory molecules CD80 or CD86, but both expressed positive costimulatory molecules CD58, CD40, CD275, CD137L, and CD252, although PC expression levels were somewhat lower. PC lacked glucocorticoidinduced TNFR-related protein (GITR) ligand, an inhibitor of regulatory T cell (Treg) function, which was expressed basally on EC and increased by treatment with IFN-␥ or tumor necrosis factor. PC more highly expressed the inhibitory molecules CD274 (programmed death [PD]-L1) and CD273 (PD-L2) than did EC, especially following treatment with IFN-␥. Unlike EC, PC did not express the adhesion molecules CD106 (vascular cell adhesion molecule-1) or E-selectin, but they did express similar levels of CD54 (intercellular adhesion molecule-1), which was further induced on both cell types following cytokine treatment (Table) . Overall, compared with umbilical vein EC, human placental PC displayed an immunophenotype expected to be less likely to activate T cell responses.
PC ؉ Do Not Effectively Stimulate Allogeneic CD4 T Cells
We directly compared the ability of placental PC and umbilical vein EC to induce allogeneic CD4 T cell responses in vitro. Peripheral blood CD4 T cells were cultured with allogeneic IFN-␥ pretreated (MHC class II molecule-expressing) vascular cells (designated PC ϩ or EC ϩ ), as well as with untreated (MHC class II molecule-negative) cells (designated PC Ϫ and EC Ϫ ). CD4 T cells cocultured with allogeneic PC ϩ produced very little IL-2 or IFN-␥ compared with cocultures with EC ϩ ( Figure 1A ). Neither cytokine was detected in cocultures of CD4 T cells with allogeneic PC Ϫ or EC Ϫ . A similar percentage of CD4 T cells cocultured with PC ϩ or EC ϩ expressed the activation markers CD69 at 24 hours and CD25 at 72 hours ( Figure 1B ), which were absent on freshly isolated CD4 T cells or CD4 T cells cocultured with PC Ϫ or EC Ϫ . A greater percentage of CD4 T cells cocultured with EC ϩ than with PC ϩ were in cell cycle or were dying at day 3 assessed by propidium iodide staining ( Figure 1C ). In contrast to CD4 T cells cocultured with allogeneic EC ϩ , CD4 T cells cocultured with allogeneic PC ϩ did not proliferate after 7 days, as assessed by carboxyfluorescein succinimidyl ester dilution ( Figure 1D ) or 5-bromo-2Ј-deoxyuridine incorporation (data not shown). The limited ability of PC ϩ compared with EC ϩ to activate allogeneic CD4 T cells was a consistent feature of multiple donor combinations ( Figure 1E ). The induction of CD69 and CD25 suggests that CD4 T cells do recognize class II MHC molecules on PC ϩ and therefore might be able to restimulate activated T cells, which have minimal need for positive costimulation. We generated activated T cells by culturing CFSE-labeled CD4 T cells with allogeneic EC ϩ for 7 days and collecting CFSE low CD4 T cells by cell sorting. Activated CD4 T cells proliferated in response to coculture with PC ϩ autologous to the primary stimulation EC ϩ but not to unrelated ("third-party") PC ϩ , assessed by 5-bromo-2Ј-deoxyuridine labeling (Figure 2A ). However, secondary proliferation to autologous PC ϩ was less than the restimulation response to autologous EC ϩ (Figure 2A ). Such differences were consistent over multiple donors ( Figure 2B ).
Table. Flow Cytometric Analysis of Immunologically Significant Cell Surface Proteins on Autologous Pericytes and Endothelial Cells
To directly assess whether the difference between PC ϩ and EC ϩ arises from differences in costimulation, we compared cocultures of vascular cells and CD4 T cells stimulated by the polyclonal-activating lectin phytohemagglutinin-L (PHA-L), an assay that is independent of MHC class II molecules but relies on costimulation provided by accessory cells. PC Ϫ or PC ϩ required increased concentrations of PHA to stimulate maximal cytokine production and proliferation by CD4 T cells compared with EC Ϫ or EC ϩ ( Figure 3A ). Furthermore, the maximum level of these responses was less in cocultures with PC than EC at saturating concentrations of PHA. As expected, no difference in CD25 induction was observed, because this response is largely mediated by T cell receptor engagement by PHA. We specifically assessed the role of negative costimulation provided by PD-1 ligands by means of antibody blocking, again using PHA to amplify the response. Addition of neutralizing antibodies to PD-1 ligands increased CD4 T cell proliferation to PC ϩ , but proliferation was still less than that observed in parallel EC ϩ cocultures at the same dose of PHA ( Figure 3B ). Thus, engagement of PD-1 contributes to, but does not fully explain, the poor accessory functions of PC. We conclude that the net balance of costimulation provided by PC is less than that provided by EC, likely resulting from quantitative differences in multiple different costimulators.
PC ؉ Induce CD4 T Cell Anergy
Because PC ϩ induced expression of the activation markers CD69 and CD25 on CD4 T cells, we investigated whether T cells demonstrate any functional change as a consequence of coculture with PC ϩ . CD4 T cells were briefly cultured with PC ϩ for 24 hours and then restimulated with either EC ϩ from the same donor as the PC ϩ or third-party EC ϩ . In these secondary cocultures, the response to matched EC ϩ resulted in less IL-2, IFN-␥, and T cell proliferation compared with secondary cocultures restimulated by third-party EC ϩ ( Figure  4A and 4B) . This functional alteration depends on recognition of class II molecules on PC because no inhibition was seen in primary cultures with PC Ϫ instead of PC ϩ , and inclusion of a human MHC class II (human leukocyte antigen-DR) blocking antibody in the primary coculture significantly decreased the degree of secondary inhibition ( Figure 4C ). In contrast, blocking PD-1 ligands in the primary culture had little effect (not shown).
Recognition of HLA-DR on PC ϩ could induce a degree of alloantigen-specific clonal anergy in CD4 T cells or could induce alloantigen-specific Treg cells capable of inhibiting responses in secondary cultures. We assessed Treg induction by immunophenotyping and by functional suppression assays, finding that coculture with PC ϩ neither induced T cell expression of characteristic Treg markers (CD4 ϩ CD25 ϩ CD127 low Foxp3 ϩ ) nor rendered T cells capable of suppressing alloresponses of freshly isolated T cells to EC ϩ (data not shown). We also saw no evidence for the Treginduced cytokines IL-10 or TGF-␤ or any effect of neutralizing these inhibitory cytokines (data not shown). We next examined CD4 T cell expression of several genes associated with human T cell anergy, specifically GRAIL, ITCH, and CBL-B. 26, 27 Activated CD25ϩ CD4 T cells cocultured with PC ϩ for 72 hours expressed increased levels of GRAIL, ITCH, and CBL-B mRNA and decreased levels of Foxp3 mRNA compared with T cells cocultured with EC ϩ (Figure 4D) . These experiments suggest that recognition of class II MHC molecules on allogeneic PC ϩ renders CD4 T cells clonally anergic.
PC ؉ Inhibit CD4 T Cell Proliferation Across a Semi-Permeable Membrane
Because many stromal cell populations reportedly modulate T cell responses via the secretion of diffusible inhibitory factors, we investigated whether PC Ϫ or PC ϩ could affect T cell responses independent of cell contact. Freshly collected PC ϩ conditioned medium showed a small inhibitory effect on CD4 T cell proliferation to EC ϩ , but the effect was inconsistent and the factor(s) appeared unstable (data not shown). In contrast, PC Ϫ or PC ϩ , but not EC Ϫ or EC ϩ , cultured across semi-permeable membranes from allogeneic EC ϩ /CD4 T cell cocultures, consistently inhibited CD4 T cell proliferation ( Figure 5A ), and PC ϩ were more potent than PC Ϫ . Inhibition was similarly observed when CD4 T cells were cocultured with EC ϩ and the superantigen toxic shock syndrome toxin-1 in the presence of PC Ϫ or PC ϩ across semi-permeable membranes (data not shown).
We examined several mechanisms used by other stromal cell types to inhibit T cell responses. We were particularly interested in those mediators that were IFN-␥ inducible in PC, because PC ϩ demonstrated greater inhibition. IFN-g treatment of PC increases mRNA levels of the tryptophan metabolizing protein IDO (Supplemental Figure Ia) , an enzyme known to be involved in human smooth muscle cell and dendritic cell inhibition of T cell responses via depletion of the essential amino acid L-tryptophan. 23, 28, 29 However, PC ϩ expression of IDO was not greater than IDO expression by donor-matched EC ϩ (Supplemental Figure Ib) , which do not suppress T cell proliferation, and neither addition of exogenous tryptophan nor addition of the IDO-antagonist 1-methyltryptophan reverses the inhibitory effect of PC ϩ in cocultures ( Figure 5B ). We also investigated whether PC might deplete cocultures of L-arginine, as human embryonic stem cells may suppress T cell responses by arginase-1-mediated L-arginine depletion. 30 Arginase-1 was not detected in cell lysates from either PC Ϫ or PC ϩ , but arginase-2 and the arginine uptake membrane transporter CAT2B were expressed and increased in PC ϩ compared with PC Ϫ (Supplemental Figure  II) . However, the addition of exogenous L-arginine did not abrogate the inhibitory effect of PC ϩ in semi-permeable mem-brane assays ( Figure 5C ). We also examined PC production of several mediators known to suppress T cell proliferation, namely nitric oxide (NO), PGE2, TGF-␤, and IL-10. Whereas inducible nitric oxide synthase (iNOS) mRNA levels were increased in PC ϩ versus PC Ϫ , iNOS protein was not detected by immunoblotting, and increased NO was not detected in the media of PC Ϫ or PC ϩ cultures (Supplemental Figure IIIa to IIIc). Furthermore, treatment of semi-permeable membrane cocultures with the specific iNOS inhibitor 1400W failed to reverse the inhibition ( Figure 5D ). PGE2 synthesis from arachidonic acid occurs constitutively by the action of COX-1 and inducibly through COX-2. COX-2 expression was slightly increased in PC ϩ versus PC Ϫ (data not shown), and PC ϩ produced increased levels of PGE2 compared with PC Ϫ (Supplemental Figure IVa) . However, medium from EC ϩ /CD4 T cell cocultures with PC Ϫ or PC ϩ across a semi-permeable membrane contained less PGE2 at 24 hours than medium from cocultures with EC across a semi-permeable membrane (Supplemental Figure IVb) . Furthermore, suppression of CD4 T cell proliferation was not reversed by treatment of cocultures with the cyclooxygenase inhibitor indomethacin ( Figure 5E ). Although neither TGF-␤ nor IL-10 appeared to be induced in PC by IFN-␥ treatment, addition of neutralizing antibodies to IL-10, TGF-␤, or both significantly relieved the inhibition of CD4 T cell proliferation caused by PC ϩ across a semi-permeable membrane ( Figure 5F ). However, the effect of neutralizing both cytokines was neither additive nor complete, suggesting that although IL-10 and TGF-␤ contribute to the inhibitory milieu, perhaps acting through the same pathway, other mechanisms must contribute as well.
We examined whether the presence of PC ϩ across a semipermeable membrane renders T cells less responsive to restimulation, as was observed in cocultures with cell-cell contact. T cells recovered from PC Ϫ and PC ϩ semi-permeable membrane cocultures responded similarly to control (EC semi-permeable membrane) T cells in secondary stimulation assays to EC ϩ (Supplemental Figure V) . In other words, PC ϩ inhibited T cell responses across a semi-permeable membrane but direct contact was necessary to induce clonal anergy.
Finally, we addressed whether placental PC are unique in their immunologic properties by investigating the immunogenicity of PC isolated from another tissue source. Human brain vascular PC were assessed for MHC, costimulatory, and adhesion molecule expression under basal and IFN-␥ stimulated conditions (Supplemental Table I ). Brain PC expressed a relatively similar immunophenotype as compared with placental PC except that not all brain PC expressed class II MHC molecules following IFN-␥ treatment. Like T cells cocultured with placental PC ϩ , CD4 T cells cocultured with brain PC ϩ did not produce IL-2 (Supplemental Figure VIa) or proliferate (Supplemental Figure  VIc) , despite induced CD25 expression (Supplemental Figure  VIb) . Brain PC also inhibited alloreactive CD4 T cell proliferation to EC ϩ across a semi-permeable membrane (Supplemental Figure VId) . Although these observations do not permit generalization to all PC, they do suggest that placental PC are not unique in their immunomodulatory functions.
Discussion
Here, we describe the ability of PC to modulate CD4 T cell responses, highlighting the regulatory effects of PC on alloreactive CD4 T cell responses to EC. In contrast to immunogenic EC ϩ , PC ϩ do not fully stimulate allogeneic CD4 T cells, likely because of a number of factors, including lower expression of MHC and positive costimulatory molecules and higher expression of inhibitory molecules, including PD-1 ligands. Nevertheless, class II MHC molecules on PC ϩ are recognized by alloreactive T cells, as evidenced by induced CD25 expression on resting T cells, proliferation of preactivated T cells, and decreased ability of lymphocytes to respond to subsequent allostimulation by the same donor. We failed to find evidence for induction of Tregs but did see increased expression of genes associated with clonal anergy. We also found that PC, like other populations of stromal cells, decrease T cell proliferation via contact-independent mechanisms mediated across a semipermeable membrane, including elaboration of IL-10 and TGF-␤. Secondary responses of T cells recovered from semipermeable membrane assays are distinct from those cultured in direct contact with PC ϩ in that responses on restimulation are unaffected in the absence of cell contact.
A number of stromal cells originating from a mesenchymal lineage reportedly modulate lymphocyte responses. Of these, MSC are the best described. 18, 19 Some investigators have proposed that PC are the resident cell population giving rise to MSC isolated from various tissues. 31 Like PC, cultured MSC express MHC class II molecules following treatment with IFN-␥ but do not stimulate T cell proliferation. MSC are thought to be poorly immunogenic because of a lack of CD80 and CD86, though it remains to be investigated whether or not MSC express other costimulatory molecules sufficient for memory T cell activation. Similarly to our findings, MSC inhibit T cell proliferation by both cell contact-dependent and cell contact-independent mechanisms in vitro. 21, 32 No single dominant mechanism for MSC-mediated lymphocyte suppression has been identified, and inhibition is believed to result from various mechanisms that depend on the antigenic stimulus 33, 34 and include tryptophan depletion by IDO, production of PGE2, and elaboration of inhibitory cytokines. Although we found evidence for the last of these mechanisms in our semi-permeable membrane system, the effects of neutralizing TGF-␤ and IL-10 were incomplete and showed no effects in direct coculture experiments. The source of these inhibitory cytokines is not entirely clear, because neither cytokine was significantly detected in the culture medium of direct T cell/PC or T cell/EC cocultures. Taken together, our results suggest that PC-mediated inhibition is multifactorial.
PC are heterogeneous, varying among different vascular beds. It should be noted that our tissue source of PC, placenta, may have influenced our findings; nevertheless, our studies using commercially available PC from human brain demonstrate that the functions described are not unique to placental PC. It remains to be seen whether they can be generalized to PC from all vascular beds.
In summary, we have provided the first evidence of an immunoregulatory function of differentiated PC isolated from a peripheral tissue and extended the properties of vascular supporting cells to include desensitization of lymphocyte responses to subsequent stimulation. Future studies are needed to address the ability of differentiated PC isolated from other tissues, especially adult peripheral tissues, to similarly inhibit T cell responses, and to address the ability of PC to modulate T cell responses in vivo.
